Approved for public listing
5-amino-1MQ 5mg
- Specification
- 5mg
- Purity
- Not published
30 vials in stock
$88.99
Information onlyCOA pending
FOXO4-DRI 2mg
Also referenced as: foxo4 dri · research · foxo4dri · longevity research
Experimental FOXO4-related peptide research focused on cellular senescence and ageing biology; evidence is predominantly preclinical. This product is supplied in the project catalogue as 2mg. Supplier availability or commercial vial strength should not be interpreted as a clinical dose or evidence of therapeutic efficacy. For laboratory research use only. Not intended for human consumption.
Research categories
Fields of laboratory research only. Not therapeutic claims, indications or evidence of efficacy.
Not currently held in stock
This specification is not currently in stock. Submit a pre-order and we confirm availability and pricing by email from orders@peptideresearch.au before any payment is taken. Pre-orders receive a 10% discount off the confirmed price.
- Specification
- 2mg
- Form
- Lyophilised powder or solution as supplied
- Purity
- [INFORMATION REQUIRED]
- Purity method
- [INFORMATION REQUIRED]
- Identity method
- [INFORMATION REQUIRED]
- Batch
- [INFORMATION REQUIRED]
- Lot
- [INFORMATION REQUIRED]
- Storage
- [INFORMATION REQUIRED]
- Stock
- Out of stock
Technical record
Documentation policy
Peptide Research publishes analytical values only where a certificate exists for the lot in question. Where a field reads pending, no verified source document has been supplied — we do not substitute typical or supplier-marketing values.
No human-use information
No dosage, reconstitution-for-administration, protocol or therapeutic-outcome information is published for any record on this site.
Related records
Approved for public listing
5-amino-1MQ 50mg
- Specification
- 50mg
- Purity
- Not published
Not currently held in stock
$123.99